About: Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 July 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в липні 2013 (uk) scientific article published on 13 July 2013 (en) مقالة علمية نشرت في 13 يوليو 2013 (ar)
publication date	wds:Q37098220-2DEBAF1D-AF6B-4222-99C7-05B1C8C91007 wds:Q37098220-FF20B7B1-EEE8-4A93-8370-84CD794C9BFD
publication date	2013-07-13 00:00:00Z (xsd:dateTime) 2013-09-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q37098220-00519793-48C3-4EB7-A1EE-E16B30826E5B wds:Q37098220-0633834A-4D94-4D07-A645-687BA3D2DA06 wds:Q37098220-1EFC8BBE-4353-4227-939F-0FE736976EB1 wds:Q37098220-47E16881-1050-437C-9BB1-58C429D8B33E wds:Q37098220-4C89A48E-7B2A-4438-A6F4-40CC1292126C wds:Q37098220-59772D3F-5E47-4F9F-88DB-22E0A50B9C04 wds:Q37098220-59F73529-654C-4D88-8779-7CD1C36717B1 wds:Q37098220-94C66889-6483-448F-9C70-D198C4D5CCF9 wds:Q37098220-9A808216-7D63-4C2D-B594-AC1AEC19A536 wds:Q37098220-A39D6A6F-1FFE-40D6-AB2F-156E22823304 wds:Q37098220-CF3E72A9-24B7-495E-9BB0-9B24F59FB8B1 wds:Q37098220-D466BE37-F437-4E98-8783-BA309C1EEEE8 wds:Q37098220-D6F86CD5-AD1B-4B5C-AA48-F91EFE9E6542 wds:Q37098220-DA2C7F33-865D-41F6-8C18-34B0953E8305 wds:Q37098220-DD02ED9D-BAE9-4390-B730-25CA3450AEF1 wds:Q37098220-E0044C4D-4253-49B5-BE21-BB267BB9C1EC wds:Q37098220-FA8D1431-AD70-4A8E-84D1-0EE00CDEB08F
cites work	Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial Therapeutic action of cannabinoids in a murine model of multiple sclerosis. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. Normalized accurate measurement of longitudinal brain change. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results Multiple sclerosis and extract of cannabis: results of the MUSEC trial. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.
author name string	wds:Q37098220-1B7A4649-F777-4D86-A3C7-9AF561B0B12A wds:Q37098220-38F3C5F2-1B22-41A0-9E9B-43B993B287AC wds:Q37098220-48DB8FEF-D98A-4BED-B483-BEB6D220D0AD wds:Q37098220-697EB316-E1F4-48F6-8C22-AA410E67FD35 wds:Q37098220-9EEED64E-ECDA-4B72-AE8B-E2FDA3CFA5AA wds:Q37098220-B4C52D77-372C-4A69-B707-D84D444C6F9A wds:Q37098220-C3BDDCB1-2BCE-430B-B414-DD70A8C3EC23 wds:Q37098220-C734E913-E737-491B-935A-97F2DB11A445 wds:Q37098220-E73E1EE2-8472-4B72-A618-21658110BDAB wds:Q37098220-E797A04D-AD61-4AE1-81DE-459C42E95FB1
author name string	Jane Vickery Jeremy Hobart John Zajicek Andrew Nunn David Wright Susan Ball David McManus Mayam Gomez Cano CUPID investigator group Sharukh Mallik
rdfs:label	Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (en) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (nl) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (ast)
skos:prefLabel	Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (en) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (nl) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (ast)
name	Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (en) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (nl) Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (ast)
author	wds:Q37098220-2B98F55C-6DD7-45FB-B0BD-452B2922269F
author	David H. Miller
title	wds:Q37098220-A8AA8E8C-BB0A-4B47-9650-90D7F81D4295
title	Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (en)
page(s)	wds:Q37098220-F9B6660A-D6E2-4D06-B7F0-056B54E3CC9B
page(s)	857-865
instance of	wds:Q37098220-2BED20CA-7797-4BE4-8093-FD438E18F80A wds:Q37098220-88894e05-4cd1-b365-c879-53a9d3714227 wds:Q37098220-A620A553-E157-4870-95AF-1802CFC2A02F wds:Q37098220-d0c30db1-4e17-032a-a3cb-967c6765259c
instance of	randomized controlled trial review article scholarly article multicenter study report
main subject	wds:Q37098220-0EA6E41C-D771-4F49-9999-62C131C8F549 wds:Q37098220-131BF365-E58C-4A9E-843D-5504531001B7

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software